1α,25-dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2

ANZ Journal of Surgery

Volumn 71, Issue 7, 2001, Pages 414-417

  Akhter, J ^a   Lu, Y ^a   Finlay, I ^a   Pourgholami, M H ^a   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Growth inhibitors; Hepatocellular carcinoma; HepG2; Proliferation; Vitamin D3

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; ANTINEOPLASTIC AGENT; CALCITRIOL; DRUG DERIVATIVE; SEOCALCITOL;

ARTICLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; HEPATOBLASTOMA; HUMAN; LIVER TUMOR; PATHOLOGY; ANALOGS AND DERIVATIVES; DRUG EFFECTS; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIVISION; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035407289     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2001.02147.x     Document Type: Article

References (19)

1. 3. Proc. Natl. Acad. Sci. USA 1981; 76: 4990-94.
2. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer proliferation. Lancet 1989; 1: 188-9.
3. 3. Cancer Res. 1987; 47: 21-5.
4. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108: 1083-6.
5. 3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells. Br. J. Surg. 1996; 83: 229-30.
6. 3 analog EB1089 inhibits growth of subcutaneous xenografts of human colon cancer cell line LoVo in a nude mouse model. Dis. Colon Rectum 1997; 40: 317-21.
7. 3 analogue EB1089 on human prostate cancer (PC3). Br. J. Urol. 1997; 80: 260-2.
8. Stuver SO. Towards global control of liver cancer? Cancer Biol. 1998; 8: 299-306.
9. 3 receptor in human liver cancer tissue. Acta Hepatol. Jpn 1988; 29: 1612-18.
10. 3 are differentially modified by 9-cis-retinoic acid. Cancer Res. 1996; 56: 623-2.
11. 3 induced growth suppression of hepatoma cells. Clin. Res. 1991; 39: 149A.
12. Masuda S, Byford V, Kremer R. In vitro metabolism of the vitamin D analog, 22-oxacalcitriol, using culture osteosarcoma, hepatoma and keratinocyte cell lines. J. Biol. Chem. 1996; 271: 8700-18.
13. 2 made in the human hepatoma, Hep3B. Biochem. J. 1995; 310: 233-41.
14. 3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation. Mol. Cell. Endocrinol. 1999; 149: 169-3.
15. 3 receptor as a marker of human colon carcinoma cell differentiation and growth inhibition. Cancer Res. 1993; 53: 3712-18.
16. 3 analogue EB1089 in human colon cancer cell line LoVo. GI Cancer 1999; 3: 17-21.
17. 3, DD-003. Cancer Res. 1994; 54: 5148-53.
18. Itin PH, Pittelknow AR, Kumar R. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 1994; 135: 1793-8.
19. 3-resistant MCF-7 cell line. Endocrinology 1996; 137: 400-9.